dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorFac Integradas Pitagoras
dc.date.accessioned2014-05-20T13:35:20Z
dc.date.accessioned2022-10-05T13:45:45Z
dc.date.available2014-05-20T13:35:20Z
dc.date.available2022-10-05T13:45:45Z
dc.date.created2014-05-20T13:35:20Z
dc.date.issued2009-04-01
dc.identifierJournal of Reproductive Medicine. St Louis: Sci Printers & Publ Inc, v. 54, n. 4, p. 239-244, 2009.
dc.identifier0024-7758
dc.identifierhttp://hdl.handle.net/11449/12147
dc.identifierWOS:000265389800009
dc.identifier9012667997804219
dc.identifier6758680388835078
dc.identifier0000-0002-9227-832X
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3888028
dc.description.abstractOBJECTIVE: To assess quality of life (QoL) and psychological aspects in patients with gestational trophoblastic disease (GTD).METHODS: This cross-sectional self-report study was conducted among 54 women. Validated questionnaires assessed QoL (WHO-QOL-bref), symptoms of depression (Beck Depression Inventory [BDI]) and anxiety (State-Trait Anxiety Inventory [STAI]).RESULTS: Most patients rated overall QoL as good (44.44%) anti were satisfied with their health status (42.59%). Mean QoL domain score was lowest for psychologic health (53.86 +/- 21.46) and highest for social relationships (65.74 +/- 22.41). BDI mean was 15.81 +/- 11.15, indicating dysphoria. STAI means were 46 +/- 6.46 for trait-anxiety and 43.72 +/- 4.23 for state-anxiety, both evidencing medium-high anxiety. Among employed patients, environment domain mean was the highest (p = 0.024). Presence of children resulted in lowest means for physical health (p = 0.041) and environment (p = 0.045). Patients desiring children showed significantly higher means for physical health (p = 0.004), psychological health (p = 0.021) and environment (p = 0.003). Chemotherapy had no significant influence on QoL (p > 0.05).CONCLUSION: This study evidenced psychological impact on GTD patients, suggesting specialized care centers should provide psychological interventions during treatment and follow-up of GTD patients, highlighting the importance of a multidisciplinary approach. (J Reprod Med 2009;54:239-244)
dc.languageeng
dc.publisherSci Printers & Publ Inc
dc.relationJournal of Reproductive Medicine
dc.relation0.452
dc.relation0,270
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectgestational trophoblastic disease
dc.subjectquality of life
dc.subjectpsychological aspects
dc.titleAssessment of Quality of Life and Psychologic Aspects in Patients with Gestational Trophoblastic Disease
dc.typeArtigo


Este ítem pertenece a la siguiente institución